AI
Friday, September 20, 2019 3:58:47 PM
$LAHO SEC, Finra say so..no greys!
..The Commission is, of course, under no obligation to accept any settlement offer and may determine not to accept a simultaneous offer of settlement and waiver request on the basis of form alone.
https://www.sec.gov/news/public-statement/clayton-statement-regarding-offers-settlement
in discussions with a market maker who has expressed preliminary interest to work with the Company on its Form 211 filing to reinstate trading of the Company’s shares on the OTC Pinks.
http://www.globenewswire.com/news-release/2019/09/20/1918533/0/en/Lans-Holdings-Plans-to-File-Form-10-with-the-SEC-and-Target-Reinstatement-of-its-Symbol-on-OTC-Pinks.html
For an uncomplicated reporting company audited by a “Big Five” firm,1
..1 An example that we identified at random was a reporting company under section 12(g) of the Exchange Act that manufactures high-technology equipment for medical, scientific, and research applications. Its stock is quoted for less than $0.50 per share..
Sam Scott Miller, Esq.
Orrick, Herrington & Sutcliffe LLP
https://www.finra.org/sites/default/files/notice_comment_file_ref/Comments%20to%20211%20Repository%20%28FINAL%29_0.pdf
match-scenario in Finra’s rule testing methodology “uncomplicated” or fast track.. future of medicine$$$
..The Commission is, of course, under no obligation to accept any settlement offer and may determine not to accept a simultaneous offer of settlement and waiver request on the basis of form alone.
https://www.sec.gov/news/public-statement/clayton-statement-regarding-offers-settlement
in discussions with a market maker who has expressed preliminary interest to work with the Company on its Form 211 filing to reinstate trading of the Company’s shares on the OTC Pinks.
http://www.globenewswire.com/news-release/2019/09/20/1918533/0/en/Lans-Holdings-Plans-to-File-Form-10-with-the-SEC-and-Target-Reinstatement-of-its-Symbol-on-OTC-Pinks.html
For an uncomplicated reporting company audited by a “Big Five” firm,1
..1 An example that we identified at random was a reporting company under section 12(g) of the Exchange Act that manufactures high-technology equipment for medical, scientific, and research applications. Its stock is quoted for less than $0.50 per share..
Sam Scott Miller, Esq.
Orrick, Herrington & Sutcliffe LLP
https://www.finra.org/sites/default/files/notice_comment_file_ref/Comments%20to%20211%20Repository%20%28FINAL%29_0.pdf
match-scenario in Finra’s rule testing methodology “uncomplicated” or fast track.. future of medicine$$$
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
